Therapeutic modulation of cerebral microhemorrhage in a mouse model of cerebral amyloid angiopathy

Stroke

Volumn 42, Issue 11, 2011, Pages 3300-3303

  Fisher, Mark ^a,b   Vasilevko, Vitaly ^c   Passos, Giselle F ^c   Ventura, Christopher ^c   Quiring, Daniel ^c   Cribbs, David H ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer; amyloid angiopathy; animal models; antiplatelet drugs; basic science; experimental; intracerebral hemorrhage; microcirculation

Indexed keywords

AMYLOID BETA PROTEIN ANTIBODY; DIPYRIDAMOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE COURSE; DRUG TOLERABILITY; FEMALE; IMMUNOTHERAPY; MALE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; VASCULAR AMYLOIDOSIS;

ANIMALS; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL HEMORRHAGE; DIPYRIDAMOLE; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOTHERAPY; MALE; MICE; MICE, TRANSGENIC; MICROCIRCULATION;

EID: 80054966360     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.626655     Document Type: Article

References (20)

1. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology. 2008;70:1208-1214. (Pubitemid 351482572)
2. Cullen KM, Kocsi Z, Stone J. Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex. J Cereb Blood Flow Metab. 2005;25:1656-1667. (Pubitemid 41683176)
3. Fisher M, French S, Ji P, Kim RC. Cerebral microbleeds in the elderly: A pathological analysis. Stroke. 2010;41:2782-2785.
4. Young VG, Halliday GM, Kril JJ. Neuropathologic correlates of white matter hyperintensities. Neurology. 2008;71:804-811.
5. Chen YW, Gurol ME, Rosand J, Vismanathan A, Rakich SM, Groover TR, et al. Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology. 2006;67:83-87. (Pubitemid 44305466)
6. Fisher M. The challenge of mixed cerebrovascular disease. Ann N Y Acad Sci. 2010;1207:18-22.
7. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci. 2001;21:372-381. (Pubitemid 32107428)
8. Wilcock DM, Rojiani A, Rosenthal A, Subbarao S, Freeman MJ, Gordon MN, et al. Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation. 2004;1:24.
9. Vasilevko V, Passos GF, Quiring D, Head E, Kim RC, Fisher M, et al. Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy. Ann N Y Acad Sci. 2010;1207:58-70.
10. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1-13. (Pubitemid 26402780)
11. Parachikova A, Vasilevko V, Cribbs DH, LaFerla F, Green K. Reductions in amyloid-beta-derived neuroinflammation, with minocycline, restores cognition but not significantly affect tau hyperphosphorylation. J Alzheimers Dis. 2010;21:527-542.
12. Kitazawa M, Vasilevko V, Cribbs DH, LaFerla FM. Immunization with amyloid-beta attenuates inclusion body myositis-like myopathology and motor impairment in a transgenic mouse model. J Neurosci. 2009;29: 6132-6141.
13. Derendorf H, VanderMaelen CP, Brickl R-S, MacGregor TR, Eisert W. Dipyridamole bioavailability in subjects with reduced gastric acidity. J Clin Pharmacol. 2005;45:845-850. (Pubitemid 40875337)
14. Robbins EM, Betensky RA, Domnitz SB, Purcell SM, Garcia-Alloza M, Greenberg SM, et al. Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease. J Neurosci. 2006;26: 365-371. (Pubitemid 43237098)
15. Han BH, Zhou M, Abousaleh F, Brendza RP, Dietrich HH, Koenigsknecht-Talboo J, et al. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid- peptide, partial restoration via-secretase inhibition. J Neurosci. 2008;28:13542-13550.
16. Petrushina I, Ghochikyan A, Mkrtichyan M, Mamikonyan G, Movsesyan N, Ajdari R, et al. Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice. J Neuroinflammation. 2008;5:42.
17. Vernooij MW, Haag MD, van der Lugt A, Hofman A, Krestin GP, Stricker BH, et al. Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol. 2009;66: 714-720.
18. Biffi A, Halpin A, Towfighi A, Gilson A, Busi K, Rost N, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology. 2010;75:693-698.
19. Kim HH, Liao JK. Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol. 2008;28:s39-s42.
20. Garcia-Bonilla L, Sosti V, Campos M, Penalba A, Boada C, Sumalla M, et al. Effects of acute post-treatment with dipyridamole in a rat model of focal cerebral ischemia. Brain Res. 2011;1373:211-220.